Cytokinetics Inc (CYTK)
Pretax margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | -589,526 | -576,402 | -545,279 | -530,598 | -526,244 | -526,728 | -539,616 | -430,799 | -388,955 | -282,145 | -215,921 | -257,655 | -215,314 | -228,674 | -155,763 | -134,989 | -127,290 | -114,000 | -140,398 | -131,731 |
| Revenue (ttm) | US$ in thousands | 18,474 | 3,219 | 3,134 | 3,752 | 7,530 | 7,815 | 9,952 | 98,053 | 94,588 | 148,231 | 151,153 | 65,028 | 70,428 | 21,550 | 57,801 | 58,551 | 55,828 | 54,318 | 18,685 | 22,229 |
| Pretax margin | -3,191.11% | -17,906.24% | -17,398.82% | -14,141.74% | -6,988.63% | -6,739.96% | -5,422.19% | -439.35% | -411.21% | -190.34% | -142.85% | -396.22% | -305.72% | -1,061.13% | -269.48% | -230.55% | -228.00% | -209.88% | -751.39% | -592.61% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $-589,526K ÷ $18,474K
= -3,191.11%
The pretax margin of Cytokinetics Inc has been highly erratic and negative over the past few years. The figures have fluctuated significantly, ranging from -592.61% to -17,906.24%. This indicates that the company's expenses and losses have consistently exceeded its revenues before accounting for taxes.
The trend shows a general pattern of worsening pretax margins over time, with occasional spikes in negative percentages, particularly in the quarters ending June 30, 2023, and September 30, 2023. However, there was a slight improvement in the pretax margin in the quarter ending December 31, 2024, compared to the previous quarters.
Overall, the consistent negative pretax margins suggest that Cytokinetics Inc has been facing challenges in controlling costs and generating sufficient revenue to cover its expenses. This trend raises concerns about the company's profitability and financial stability. Further analysis of the company's financial statements and operational efficiency is advisable to understand the underlying reasons for these poor pretax margin figures.
Peer comparison
Dec 31, 2024